2023 Oncology & Precision Medicine Conference

2023 Oncology & Precision Medicine Conference

Alderley Park Conference Centre
Tuesday 14th & Wednesday 15th November 2023

Event Logo


Following the success of 2022’s events, the Oncology Conference and the Precision Medicine Conference is BACK and running on two consecutive days. Join Bionow, expert speakers and industry colleagues to discuss the current oncology landscape on day one and the future of precision medicine on day two.

The prevention of cancer and the development of more effective strategies for early-stage detection, when treatment may be most effective, remain critical societal goals. Precision medicine is the next generation of healthcare research that has the potential to provide significant, targeted benefits to patients, and effect strategic shifts in the way healthcare is delivered. Bionow is pleased to once again present a two-day event to explore the relationship between these two areas of healthcare and facilitate a more in-depth programme, including talks, panel discussions and networking opportunities.

The oncology portion of the conference will cover the issues surrounding prevention and early diagnosis, new approaches to cancer research and treatments of the future, followed by a look at patient perspectives and rare cancer research. We will hear from experts, organisations and patient advocacy groups. 
Precision Medicine
The second day of the conference will focus on the impact precision medicine is having on patients in the detection, treatment and prevention of diseases and how we are developing this approach in an efficient and sustainable way. Topics will cover a state of the nation discussion, a deep dive into precision medicine in chronic and rare diseases, and patient perspectives.

Organisations that attended the 2022 conferences:

Agile Life Sciences, Air Products, Ambit, Apex Molecular, Apis Assay Technologies Ltd, Aptamer Group, ATG Scientific Ltd, Biocair, BioPartner UK, Bivictrix, BMG Labtech, Cancer Research, Charles River, Chris Doherty, Cizzle Biotech, DXCOVER, FOx Biosystems, Hull University, Illumina, Keele University, Lancaster University, Lean Life Science, LS Law, Manchester Uni, Marks & Clerk, Medicines Discovery Catapult, Mills & Reeve, Monument Therapeutics, Nonacus, North West Cancer Research, Omecu, Pinpoint Data Solutions, QIAGEN, Sheffield University, Source BioScience, Spotlight Pathology, SRG, Sygnature Discovery, The University of Bradford, The University of Manchester, VOCAL, VRS Recruitment, Yourgene Health UK Ltd, Zilico

For further information on the exciting exhibitor opportunities available, check out the range of packages here.

These WILL SELL OUT so secure your space now!

Key Information

Oncology Conference

Tuesday 14th November 

Precision Medicine Conference

Wednesday 15th November 


Alderley Park Conference Centre


  • 09:05 Conference Welcome

    Andy Roberts, Innovation Manager, Bruntwood SciTech

  • 09:10 Keynote

    Professor David Sebag-Montefiore, Academic Clinical Oncologist & Honorary Clinical Oncologist, University of Leeds & Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust

    • Professor David Sebag-Montefiore, Academic Clinical Oncologist & Honorary Clinical Oncologist, University of Leeds & Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust
  • 09:30 Early Detection and Diagnosis

    Chair: Harminder Singh, Director, TRUPCR Europe

    Amr Ahmed, Head of Department Computer Sciences, Edge Hill University

    James Nightingale, Observational Cosmologist and Royal Society Short Industry Fellow, Durham University

    Prashant Agrawal, Assistant Professor, Northumbria University

    Ihtesham ur Rehman, Head of Translational Research, UCLan

  • 10:30 Coffee, Networking & Exhibition

  • 11:05 New Approaches in Cancer Research

    Chair: Stella James, Executive Director Business Development, Bionow

    Annelise Soulier, Co-Founder & CSO, Neobe Therapeutics

    Munitta Muthana, CSO, NANOncolytics & Faith Howard, CEO, NANOncolytics

    Andrew Fielding, Senior Lecturer in Cancer Research, Lancaster University

    Steve Myatt, CEO, Macomics 

  • 12:05 Treatments of the Future

    Chair: Andy Jones, Founder and Director, MedrusPharma Consulting

    Louise Scott, Director, Oncology Drug Development, Catalyst Oncology 

    Stuart Farrow, Vice President of Biosciences, Cancer Research Horizons

    Suzanne Dilly, CEO, ValiRx

  • 13:05 Lunch, Networking & Exhibition

  • 14:15 Keynote

    Caroline Dive, Interim Director of the Institute and Director, CRUK Cancer Biomarker Centre  

    • Caroline Dive , Interim Director of the Institute and Director, CRUK Cancer Biomarker Centre
  • 14:35 Catalyst Oncology

    Shamim Kazmi-Stokes, Project Director, Catalyst Oncology

    Amy Nguyen, Vice President, Business Development & Relationship Management Catalyst Oncology

  • 14:55 Rare Cancers & Patient Perspective

    Chair: Andy Hall, Co-Founder & CSO, RareCan

    Vicky Rockingham, RareCan

    Matthew Krebs, Clinical Senior Lecturer, University of Manchester

    Lisa Lee Tokar, Senior Field Application Scientist - Oncology, Illumina

    Zoe Davison, Head of Research & Information, Bone Cancer Research Trust

    Gareth Thomas, Trustee, Oracle Cancer Trust

    Ramsay McFarlane, Director, Ceridwen Oncology 

  • 16:30 Coffee, Networking & Exhibition

  • 17:00 Biotech & Beers at the Churchill Tree Alderley Park

  • 09:00 Conference Welcome

    Simon Bradbury, Partner, Appleyard Lees

  • 09:05 AstraZeneca - Precision Medicine & Biosamples

    Jason Swift, Head of Digital Transformation Precision Medicine & Biosamples, R&D Oncology AstraZeneca

  • 09:15 State of the Nation

    Chair: Steve Little, Biotech Founder, Director and Supporter

    Jason Swift, Head of Digital Transformation, Precision Medicine & Biosamples, R&D Oncology AstraZeneca

    Nathan McNally, Capital Enterprise Health & Life Science Director, P4 Precision Medicine

    Simon Bradbury, Partner, Appleyard Lees

    Michael Nation, Director, Kidney Research UK

  • 10:25 Coffee, Networking & Exhibition

  • 10:55 Keynote

    Professor Sir Munir Pirmohamed, Non- executive Director, NHS England & Director; David Weatherall Chair of Medicine, University of Liverpool

  • 11:15 Precision Medicine in Chronic Diseases

    Chair: Geoff Davison, CEO, Bionow

    Jess Neisen, Director and Team Leader, Immunology Translational Science and Precision Medicine, AstraZeneca

    Alistair Bounds, Senior Reseacrh Scientist, Occuity 

    Klaudia Kocsy, Postdoctorial Research Associate, University of Sheffield

    Martin Main, CSO, Medicines Discovery Catapult 

  • 12:15 Pharmacogenomics for Precision Dosing

    Tiffany Morris, Staff Market Development Manager Precision Health & Pharmacogenomics, Europe Illumina

  • 12:45 Lunch, Networking & Exhibition

  • 14:00 Keynote

    Joanne M. Hackett, Head of Genomics and PM, IQVIA  Part of AHSN Network

  • 14:20 Precision Oncology: Applications for dPCR in Cancer genomics

    Glyn Ball, Sen Manager, MDx Assay Development, R&D Europe, QIAGEN

  • 14:30 Revolutionizing Detection: Unveiling the Genomic Landscape with Next-Generation

    Nathan Dennison, Product Development Lead, QIAGEN

  • 14:40 Precision Medicine in Rare Diseases

    Bob Clay, Senior Regulatory Advisor, Highbury Regulatory Science

    Lee Dunham, Director of Business Development, Cell & Gene Therapy Catapult

    Robert Mitchell, Head of Development, Micregen

    Richard Gallon, Research Associate, Commercial Enterprise, The Newcastle upon Tyne Hospitals NHS Foundation Trust 

  • 15:40 Coffee, Networking & Exhibition

  • 16:00 Networking & Close

Gold Exhibitors






Registration will open shortly. For any further queries please contact info@bionow.co.uk



Alderley Park Conference Centre
Alderley Park, Nether, Alderley Sk10 4Tg, Alderley Edge SK10 4TG


To reach the Mereside Campus: When approaching the Park please head towards the North entrance (sign posted Alderley Park North) and park in any multi-storey car park on your left. Mereside entrance is a short walk opposite the car parks.


Alderley Park is centrally located within easy reach of the M6 and M56 motorway network. It is located just 18 miles away from Manchester city centre and 20 minutes from Manchester Airport which offers flights to 225 destinations around the world. The Park offers easy access to Manchester and the rest of the UK by train with three local stations (Alderley Edge, Wilmslow and Macclesfield) all within 15 minutes drive.